DoMark International Inc. Donates Performance Enhancing Technology by Noraxon to Assist Physio Expert to World's Top Track Athletes in Preparation for the 2012 Olympic Games

DoMark International Inc. (OTCBB: DOMK) (the "Company" or "DoMark"), through its wholly owned subsidiary, MuscleFoot Inc., is pleased to announce that it has donated revolutionary Noraxon equipment to Sean Peña, physio and biomechanics expert to the world’s top track athletes, to assist in developing his clients ahead of the London 2012 Olympic Games. In addition to helping his track and field clients, Mr. Peña will have the opportunity to harness the advanced performance measurement capabilities of the Noraxon system to aid his world class athletic clientele from the equestrian, NFL football, and US Olympics and Track & Field arenas. In combination with patented Barefoot Science technology by MuscleFoot Inc., which rehabilitates weak foot muscles and improves athletic performance, the donated Noraxon technology will vastly aid Mr. Peña in optimizing his clients’ biomechanics and adjusting their training regimens.

Sean Peña is the personal physio and biomechanics expert for many of the world’s top track and field athletes. Notable clients who by the release of this announcement had secured places on the US Olympic team include Justin Gatlin, Mike Rogers, William Claye, Joel Brown, and LoLo Jones. Mr. Peña also works with Olympic hopefuls, Brittany Reese and David Oliver, who continue to pursue spots on the US team. All of the previously mentioned athletes are using Barefoot Science insole system to prepare for the 2012 London Olympics.

“Using this high level technology will allow me to improve the performance and decrease the risk of injuries to my clients by observing in an utterly accurate way the motion and performance of the athlete. Along with Barefoot Science, I will be able to fine tune both the highest level athlete and the average person to correct biomechanics. Technology like this was previously only available in a clinic or lab setting and will now be implemented real time towards functional activities,” said Sean Peña.

The full system consists of a Clinical DTS (wireless EMG) 4-channel, instrumented treadmill with MyoVideo, and a FDM-SX pressure plate. The goal of this three component system is to provide complete insight into the full body mechanics that control the athlete’s gait. This system measures vertical force and ground reaction forces, underfoot pressure, temporal and special gait parameters, and provides insight into muscle innervations, symmetry and coordination. The system’s 2D kinematics functionality can track height, distance, and angular data. In short, the Noraxon technology donated by DoMark provides a complete, ‘inside and out’ picture of what is happening within the human body, and allows training staff to modify training routines and make performance adjustments based on real-time intelligent data.

Noraxon systems have recorded an instant decrease of 50% in postural sway or increase in balance/ stability as well as a significant increase in major gait related muscle efficiency and strength in subjects tested after using the patented Barefoot Science insole system. This donation is part of a drive on the part of MuscleFoot Inc. to demonstrate the power of Barefoot Science’s patented foot technology as an integral component of performance enhancement and pain relief for individuals from across the spectrum of amateur, elite, and professional athletics.

“Donating this piece of technology to Sean will enhance his clients’ performance immensely, and we are pleased to help him attain even more credibility in his field as one of the top sports physios on the planet and help his clients to maximize their full potential,” said VP of Corporate Development, Patrick Johnson.

Barefoot Science is revolutionizing the $223 billion global footwear and $3.5 billion foot care markets with its patented insole technology. For over 15 years, Barefoot Science has studied foot biomechanics, as well as the capabilities of its products to actively stimulate, strengthen, and restore the foot. This is significant disruptive foot therapy technology that will revolutionize the foot care industry. Applied either through an insole placed inside the shoe, or by integration directly into the design of the shoe, Barefoot Science technology prevents and rehabilitates a wide range of foot, leg, and back ailments, and enhances athletic performance. Barefoot Science backs these claims with a wealth of scientific research and endorsements from thousands of customers who currently use Barefoot Science insoles.

Follow Sean Peña and the US Olympic candidates mentioned in this announcement:

About DoMark International Inc.

DoMark is a marketing and management company engaged in owning, developing, and marketing a variety of patented game changing consumer products through its wholly owned subsidiaries, SolaWerks, Inc. and Musclefoot Inc. Solawerks develops and distributes the SolaPad and SolaCase combined cover and solar charging systems for Apple's iPad and iPhone. Musclefoot Inc. distributes, markets, and acts as sales agent for the revolutionary patented foot care system, Barefoot Science. With a strong commitment to customer service and security, and a proven and capable marketing team, DoMark intends to expand its marketing relationships across a far greater product set.

For more information on the DoMark, visit www.domarkintl.com.

For more information on MuscleFoot Inc., visit www.musclefoot.com.

For more information on Barefoot Science products, visit www.barefoot-science.com.

For more information on SolaWerks products, visit www.solawerks.com.

This news release may contain certain forward-looking information. All statements included herein, other than statements of historical fact, are forward-looking information and such information involves various risks and uncertainties. There can be no assurance that such information will prove to be accurate, and actual results and future events could differ materially from those anticipated in such information. A description of assumptions used to develop such forward-looking information and a description of risk factors that may cause actual results to differ materially from forward-looking information can be found in the Corporation's disclosure documents on the SEDAR website at www.sedar.com. The Corporation does not undertake to update any forward-looking information except in accordance with applicable securities laws.